PLRZ Signs $15M CRO Deal for Preclinical Studies, Advances Nasal Hydrogel Platform Toward Clinical Trials
Polyrizon Ltd. Ordinary Shares · Now $15.41
+13% since the alert
$13.60 → $15.41
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS